Defining baseline high-sensitivity cardiac troponin levels in healthy collegiate athletes
American Journal of Clinical Pathology · 05.05.2026 · 165 (5)
DOI: 10.1093/ajcp/aqag042 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 19.05.2026. Verfasst von Yaseen A Jamal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States. Hauptthemen laut MEDLINE: Troponin I, Athletes. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Department of Pathology, Stanford University School of Medicine.
Abstract (Originalsprache)
Objectives
Cardiac troponin (cTn) is a critical biomarker for diagnosing myocardial injury; however, intense physical activity can transiently elevate cTn concentrations, creating diagnostic challenges in athletic populations. High-sensitivity cardiac troponin assays (hs-cTn) further complicate discrimination between physiologic and pathologic elevations.
Methods
This study characterized baseline high-sensitivity cardiac troponin I (hs-cTnI) distributions in collegiate athletes and evaluated associations with sex, time since exercise, sport type, and creatine kinase–MB (CK-MB). We analyzed baseline hs-cTnI values from 173 elite collegiate athletes (98 women, 75 men) representing 21 sports.
Results
The median hs-cTnI concentration (<4 ng/L) was identical between sexes, but divergence emerged in the upper distribution tail, with hs-cTnI values exceeding population-derived 99th percentile upper reference limits occurring at lower percentiles in men than women (73rd vs 85th percentile), resulting in a higher prevalence of abnormal classifications in men (28% vs 17%, P < .01). Ninety-fifth percentile values were similar between sexes, whereas divergence was confined to the extreme upper tail (99th percentile). Abnormal hs-cTnI values were more frequent when samples were collected <48 hours after exercise compared with ≥48 hours (29% vs 16%, P = .04). No association was observed between hs-cTnI and CK-MB (P = .37). Significant differences emerged between sports (P = .02), with the highest proportions of abnormal hs-cTnI observed among cross-country (80%), sailing (44%), and rowing (35%) athletes.
Conclusions
These findings support athlete-focused interpretation of hs-cTnI incorporating sex-specific thresholds, standardized postexercise sampling, and sport context. Such tailored approaches may reduce false-positive results and unnecessary evaluations while preserving diagnostic accuracy for true myocardial pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
- Department of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
- Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, CA, United States.
ORCID-Profile: Yaseen A Jamal, Francois Haddad, Raffick A R Bowen
Förderung
- Department of Pathology, Stanford University School of Medicine
Zitieren
APA
Jamal, Y. A., Montiel, A., Jones, S., Nair, P., Parikh, V., Haddad, F., Wheeler, M. T., Hwang, C., Tso, J. V., & Bowen, R. A. R. (2026). Defining baseline high-sensitivity cardiac troponin levels in healthy collegiate athletes. American Journal of Clinical Pathology, 165(5). https://doi.org/10.1093/ajcp/aqag042
Vancouver
Jamal YA, Montiel A, Jones S, Nair P, Parikh V, Haddad F, et al. Defining baseline high-sensitivity cardiac troponin levels in healthy collegiate athletes. American Journal of Clinical Pathology. 2026;165(5). doi:10.1093/ajcp/aqag042
BibTeX
@article{Jamal2026,
author = {Jamal, Yaseen A and Montiel, Avery and Jones, Skyler and Nair, Priyanka and Parikh, Victoria and Haddad, Francois and Wheeler, Matthew T and Hwang, Calvin and Tso, Jason V and Bowen, Raffick A R},
title = {Defining baseline high-sensitivity cardiac troponin levels in healthy collegiate athletes},
journal = {American Journal of Clinical Pathology},
year = {2026},
volume = {165},
number = {5},
doi = {10.1093/ajcp/aqag042}
}
EUVIMED